CAS 801312-28-7 appears in our catalog under these names: Gsk256066, 95%, GSK256066, 98+%, GSK256066, 6-[[3-[(Dimethylamino)carbonyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide, 98%, 98%, GSK256066, 98.69%. Offered by: Combi-blocks, AmBeed, GLPBio, TargetMol, Chemat. Available pack sizes: 100mg, 25mg, 10mg, 200mg, 50mg, 1mg, 2mg, 5mg.
GSK-256066 is gsk256066 has been used in trials studying the treatment and diagnostic of SAR, Asthma, Mild Asthma, Allergic Rhinitis, and Seasonal Allergic Rhinitis, among others.
Source: ChEBI
| Molecular formula | C27H26N4O5S |
|---|---|
| Molecular weight | 518.6 g/mol |
| IUPAC name | 6-[3-(dimethylcarbamoyl)phenyl]sulfonyl-4-(3-methoxyanilino)-8-methylquinoline-3-carboxamide |
| InChIKey | JFHROPTYMMSOLG-UHFFFAOYSA-N |
| SMILES | CC1=CC(=CC2=C(C(=CN=C12)C(=O)N)NC3=CC(=CC=C3)OC)S(=O)(=O)C4=CC=CC(=C4)C(=O)N(C)C |
Computed by PubChem (NCBI)